These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18571695)

  • 1. Interferon-gamma is increased in patients with primary Sjogren's syndrome and Raynaud's phenomenon.
    Willeke P; Schlüter B; Schotte H; Domschke W; Gaubitz M; Becker H
    Semin Arthritis Rheum; 2009 Dec; 39(3):197-202. PubMed ID: 18571695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and immunological characteristics of patients with Sjögren's syndrome in relation to alpha-fodrin antibodies.
    Willeke P; Gaubitz M; Schotte H; Becker H; Mickholz E; Domschke W; Schlüter B
    Rheumatology (Oxford); 2007 Mar; 46(3):479-83. PubMed ID: 16935916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T regulatory cells are markedly diminished in diseased salivary glands of patients with primary Sjögren's syndrome.
    Li X; Li X; Qian L; Wang G; Zhang H; Wang X; Chen K; Zhai Z; Li Q; Wang Y; Harris DC
    J Rheumatol; 2007 Dec; 34(12):2438-45. PubMed ID: 18050367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of CD4+ CD25+ regulatory T cells in peripheral blood and salivary gland of patients with primary Sjögren's syndrome].
    Li XM; Li XP; Qian L; Wang GS; Zhang H; Zhei ZM; Li Q; Chen K; Wang XQ; Wang YP
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1034-6. PubMed ID: 17672966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased CD4+CD25+bright T cells in peripheral blood of patients with primary Sjogren's syndrome.
    Liu MF; Lin LH; Weng CT; Weng MY
    Lupus; 2008 Jan; 17(1):34-9. PubMed ID: 18089681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of immunomodulatory interleukins for the hyperimmunoglobulinemia of Sjögren's syndrome.
    Girón-González JA; Baturone R; Soto MJ; Márquez M; Macías I; Montes de Oca M; Medina F; Chozas N; García-Pérez S
    Cell Immunol; 2009; 259(1):56-60. PubMed ID: 19540455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological alterations in newly diagnosed primary Sjögren's syndrome characterized by skewed peripheral T-cell subsets and inflammatory cytokines.
    Szodoray P; Gal I; Barath S; Aleksza M; Horvath IF; Gergely P; Szegedi G; Nakken B; Zeher M
    Scand J Rheumatol; 2008; 37(3):205-12. PubMed ID: 18465456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain-derived neurotrophic factor and nerve growth factor correlate with T-cell activation in primary Sjogren's syndrome.
    Fauchais AL; Boumediene A; Lalloue F; Gondran G; Loustaud-Ratti V; Vidal E; Jauberteau MO
    Scand J Rheumatol; 2009; 38(1):50-7. PubMed ID: 18830907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement inhibitor C4b-binding protein in primary Sjögren's syndrome and its association with other disease markers.
    Zadura AF; Theander E; Blom AM; Trouw LA
    Scand J Immunol; 2009 Apr; 69(4):374-80. PubMed ID: 19284503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raynaud's phenomenon in primary Sjögren's syndrome. Association with other extraglandular manifestations.
    Kraus A; Caballero-Uribe C; Jakez J; Villa AR; Alarcón-Segovia D
    J Rheumatol; 1992 Oct; 19(10):1572-4. PubMed ID: 1464870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased serum levels of macrophage migration inhibitory factor in patients with primary Sjögren's syndrome.
    Willeke P; Gaubitz M; Schotte H; Maaser C; Domschke W; Schlüter B; Becker H
    Arthritis Res Ther; 2007; 9(2):R43. PubMed ID: 17470266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life in patients with primary Sjögren's syndrome: relationship with serum levels of proinflammatory cytokines.
    Baturone R; Soto MJ; Márquez M; Macías I; de Oca MM; Medina F; Chozas N; García-Pérez S; Girón-González JA
    Scand J Rheumatol; 2009; 38(5):386-9. PubMed ID: 19575332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjögren's syndrome.
    Lavie F; Miceli-Richard C; Ittah M; Sellam J; Gottenberg JE; Mariette X
    Scand J Immunol; 2008 Feb; 67(2):185-92. PubMed ID: 18201372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of T-helper cells in patients with primary Sjogren's syndrome.
    Sudzius G; Mieliauskaite D; Butrimiene I; Siaurys A; Mackiewicz Z; Dumalakiene I
    In Vivo; 2013; 27(2):263-8. PubMed ID: 23422488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4 CD25high regulatory T cells are not impaired in patients with primary Sjögren's syndrome.
    Gottenberg JE; Lavie F; Abbed K; Gasnault J; Le Nevot E; Delfraissy JF; Taoufik Y; Mariette X
    J Autoimmun; 2005 May; 24(3):235-42. PubMed ID: 15848046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome.
    Ittah M; Miceli-Richard C; Eric Gottenberg J; Lavie F; Lazure T; Ba N; Sellam J; Lepajolec C; Mariette X
    Arthritis Res Ther; 2006; 8(2):R51. PubMed ID: 16507175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase 9 (MMP-9) gene polymorphism and MMP-9 plasma levels in primary Sjogren's syndrome.
    Hulkkonen J; Pertovaara M; Antonen J; Pasternack A; Hurme M; Pöllänen P; Lehtimäki T
    Rheumatology (Oxford); 2004 Dec; 43(12):1476-9. PubMed ID: 15316122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of interferon regulatory factor 1, 3, and 7 in primary Sjögren syndrome.
    Zheng L; Yu C; Zhang Z; Yang C; Cai X
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 May; 107(5):661-8. PubMed ID: 19426920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of T-cell large granular lymphocyte leukemia associated with Sjogren's syndrome-an important but under-recognized association.
    Friedman J; Schattner A; Shvidel L; Berrebi A
    Semin Arthritis Rheum; 2006 Apr; 35(5):306-11. PubMed ID: 16616153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunohistochemical study of inflammatory infiltrates in minor salivary glands in Sjögren's syndrome and other autoimmune diseases].
    Tomás S; Coll J; Reth P; Corominas JM
    Med Clin (Barc); 1998 Nov; 111(18):681-6. PubMed ID: 9887430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.